Cited by 61Genetic Associations and EpidemiologyMetabolism, Diabetes, and CancerGenetics and Physical Performance

Genetic Variants in Promoters and Coding Regions of the Muscle Glycogen Synthase and the Insulin-Responsive GLUT4 Genes in NIDDM

Bjørbæk, Christian, Echwald, Søren M, Hubricht, Peter, Vestergaard, Henrik, Hansen, Torben, Zierath, Juleen, Pedersen, Oluf·1994·Diabetes

Abstract

To examine the hypothesis that variants in the regulatory or coding regions of the glycogen synthase (GS) and insulin-responsive glucose transporter (GLUT4) genes contribute to insulin-resistant glucose processing of muscle from non-insulin-dependent diabetes mellitus (NIDDM) patients, promoter regions and regions of importance for translation, as well as coding sequences of the two genes, were studied using single-strand conformation polymorphism (SSCP) analysis and DNA sequencing. The genetic analyses were performed in subgroups of 52 Caucasian NIDDM patients and 25 age-matched healthy volunteers. By applying inverse polymerase chain reaction and direct DNA sequencing, 532 base pairs (bp) of the GS promoter were identified and the transcriptional start site determined by primer extension. SSCP scanning of the promoter region detected five single nucleotide substitutions, positioned at 42, –16, –43, –143, and –250. The three most common variants could be excluded for having major impact on allele-specific GS mRNA expression in muscle. Scanning of GS cDNA revealed one frequent silent polymorphism at codon 342. Moreover, SSCP analysis of ∼900 bp of the promoter, the 5′-untranslated region, and the coding region of the GLUT4 gene showed four polymorphisms, all single nucleotide substitutions, positioned at –581, 1, 30, and 582. None of the three changes in the regulatory region of the gene had any major influence on expression of the GLUT4 gene in muscle. The variant at 582 in the GLUT4 cDNA was a silent polymorphism at codon 130. Southern blotting of both gene loci did not detect any major abnormalities. These findings, altogether, suggest that genetic abnormalities in the GS and GLUT4 genes are unlikely to be major contributors to the insulin-resistant glucose utilization in muscle among Caucasian NIDDM patients.

Integrity signals

Registry

Crossref · 10.2337/diab.43.8.976

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNA sequencing of the glycogen synthase gene has found either no mutations or rare nucleotide substitutions that cannot explain the defect in insulin-stimulated glycogen synthase activity in type 2 diabetes.

    “The glycogen synthase gene has been the subject of intensive investigation, and DNA sequencing has revealed either no mutations or rare nucleotide substitutions that cannot explain the defect in insulin-stimulated glycogen synthase activity [223–225].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [225]

The citation lists haven’t been fetched yet

References 32 · Cited by 61

Authors
Bjørbæk, C., Echwald, S. M., Hubricht, P., Vestergaard, H., Hansen, T., Zierath, J., & Pedersen, O.
Affiliations
Steno Diabetes Center Copenhagen (DK)
Venue
Diabetes
Published
1994-08-01
Volume
43
Issue
8
Pages
976-983
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2018422684
Cited by
61
References
32
Citations by year
2025: 1 · 2022: 3 · 2019: 1 · 2018: 2 · 2017: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 2
FWCI
3.16
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Velux Stiftung
  • Diabetesforeningen
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
Keywords
type 2 diabetes, glycogen synthase, GLUT4, glucose transporters, promoter polymorphism, single nucleotide polymorphisms, muscle insulin resistance, transcription start sites, silent polymorphism, 5' untranslated region, gene expression, genetic variants
MeSH terms
Adult, Aged, Base Sequence, Chromosomes, Human, Pair 17, Diabetes Mellitus, Type 2, DNA, DNA, Single-Stranded, Female, Glycogen Synthase, Humans, Insulin, Male, Middle Aged, Molecular Sequence Data, Monosaccharide Transport Proteins, Muscle Proteins, Muscles, Polymorphism, Genetic, Promoter Regions, Genetic, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Genetic Variation, Blotting, Southern, Polymerase Chain Reaction, Glucose Transporter Type 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review